Craig Hallum initiated coverage on Actuate Therapeutics with a new price target

4/22/25 8:00:39 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Craig Hallum initiated coverage of Actuate Therapeutics with a rating of Buy and set a new price target of $21.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ACTU

Date	Price Target	Rating	Analyst
4/22/2025	$21.00	Buy	Craig Hallum
3/17/2025	$20.00	Buy	H.C. Wainwright